Summary of Significant Accounting Policies - Basis of Presentation and Going Concern (Details) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | 6 Months Ended | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
May 15, 2026 |
May 10, 2026 |
Jan. 21, 2026 |
May 09, 2024 |
Jun. 30, 2026 |
Mar. 31, 2026 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Dec. 31, 2025 |
Aug. 18, 2025 |
Aug. 17, 2025 |
Aug. 14, 2025 |
May 07, 2025 |
Oct. 02, 2022 |
|
| Concentration Risk [Line Items] | ||||||||||||||||
| Cash and cash equivalents | $ 44,977 | $ 44,977 | $ 13,164 | |||||||||||||
| Accumulated deficit | (848,928) | (848,928) | $ (1,018,554) | |||||||||||||
| Cash used in operating activities | (10,656) | $ (42,815) | ||||||||||||||
| Net income (loss) | $ 184,305 | $ (14,679) | $ (32,499) | $ (19,229) | $ 169,626 | $ (51,728) | ||||||||||
| Common shares, par value (usd per share) | $ 0.0000001 | $ 0.0000001 | $ 0.0000001 | $ 0.0000001 | $ 0.0001 | $ 0.0001 | $ 0.0000001 | |||||||||
| Shares issued in transaction (in shares) | 2,000,000 | |||||||||||||||
| Stock price (usd per share) | $ 0.24 | $ 10.00 | ||||||||||||||
| Purchase price | $ 20,000 | |||||||||||||||
| Sale of stock price (usd per share) | $ 10.00 | |||||||||||||||
| Private Placement | ||||||||||||||||
| Concentration Risk [Line Items] | ||||||||||||||||
| Common shares, par value (usd per share) | $ 0.0000001 | |||||||||||||||
| Shares issued in transaction (in shares) | 1,000,000 | 4,000,000 | ||||||||||||||
| Stock price (usd per share) | $ 5.00 | |||||||||||||||
| Purchase price | $ 10,000 | $ 20,000 | ||||||||||||||
| Issuance of common stock in private placement (in shares) | 510,968 | |||||||||||||||
| Sale of stock price (usd per share) | $ 10.00 | |||||||||||||||
| At Market Issuance Sales | ||||||||||||||||
| Concentration Risk [Line Items] | ||||||||||||||||
| Shares issued in transaction (in shares) | 2,000,000.0 | |||||||||||||||
| Purchase price | $ 100,000 | $ 100,000 | ||||||||||||||
| X | ||||||||||
- Definition Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of accumulated undistributed earnings (deficit). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Cash received on stock transaction after deduction of issuance costs. No definition available.
|
| X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
| X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
| X | ||||||||||
- Definition Price of a single share of a number of saleable stocks of a company. No definition available.
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|